Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

LITS

Lite Strategy Inc

May 08 • 04:00PM ET

1.22

+0.08 7.02 %

Healthcare • Biotechnology • USA • Nano • NASD

Peers: OCGN BLRX TNXP BCDA ADIL

| Held by: VTI VXF

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-1.74	Insider Own	11.39%	Shs Outstand	36.65M	Perf Week	7.96%
Market Cap	44.36M	Forward P/E	-	EPS next Y	-	Insider Trans	-12.81%	Shs Float	32.22M	Perf Month	4.27%
Enterprise Value	35.60M	PEG	-	EPS next Q	-	Inst Own	22.55%	Short Float	0.20%	Perf Quarter	15.09%
Income	-39.70M	P/S	-	EPS this Y	-	Inst Trans	-7.04%	Short Ratio	0.23	Perf Half Y	-34.05%
Sales	0.00M	P/B	0.55	EPS next Y	-	ROA	-73.98%	Short Interest	0.07M	Perf YTD	-7.58%
Book/sh	2.23	P/C	5.06	EPS next 5Y	-	ROE	-76.38%	52W High	9.00 -86.44%	Perf Year	-41.35%
Cash/sh	0.24	P/FCF	-	EPS past 3/5Y	37.89% 25.03%	ROIC	-48.50%	52W Low	0.95 28.29%	Perf 3Y	-77.53%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	5.05% 4.61%	Perf 5Y	-97.63%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	69.71%	Oper. Margin	-	ATR (14)	0.06	Perf 10Y	-94.14%
Dividend Ex-Date	Nov 16, 2023	Quick Ratio	10.04	Sales Y/Y TTM	-100.00%	Profit Margin	-	RSI (14)	57.81	Recom	2.33
Dividend Gr. 3/5Y	- -	Current Ratio	10.04	EPS Q/Q	-105.10%	SMA20	4.77%	Beta	0.25	Target Price	22.67
Payout	-	Debt/Eq	0.00	Sales Q/Q	-	SMA50	5.06%	Rel Volume	3.44	Prev Close	1.14
Employees	4	LT Debt/Eq	0.00	Earnings	-	SMA200	-43.20%	Avg Volume	281.99K	Price	1.22
IPO	Dec 18, 2003	Option/Short	Yes / Yes	EPS/Sales Surpr.	- -	Trades		Volume	969,334	Change	7.02%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)